A Study of C-CAR039 Treatment in Subjects With r/r NHL SubjectsNon-Hodgkin's Lymphoma

Clinical trial NCT04696432 · COMPLETED

Trial details

NCT number: NCT04696432
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Hodgkin's B-cell Lymphoma

Start date: 2020-11-27
Primary completion: 2023-07-31
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.